NeoImmuneTech to Partner with U.S. National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) for Drug Development in Acute Radiation Syndrome (ARS)

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://neoimmunetech.com/board/view.html?Ncode=b1&number=218&sWord=&n_list=0&page=1
Research Institution
NeoImmuneTech, Inc.
Short Title
NeoImmuneTech to Partner with U.S. National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) for Drug Development in
Content Coordinator
Claudia Wair
Content Manager
Catey Laube Macdonald

How A Viral Toxin May Exacerbate Severe COVID-19

A Three-Dose Malaria Vaccine Shows Safety, Efficacy in West African Adults

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://www.medschool.umaryland.edu/news/2022/A-Three-Dose-Malaria-Vaccine-Shows-Safety-Efficacy-in-West-African-Adults.html
Research Institution
University of Maryland School of Medicine
Short Title
A Three-Dose Malaria Vaccine Shows Safety, Efficacy in West African Adults
Content Coordinator
Claudia Wair
Content Manager
Catey Laube Macdonald

Research Identifies Potential Genetic Cause for MIS-C Complication Following COVID-19 Infection

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://newsroom.clevelandclinic.org/2022/12/20/research-identifies-potential-genetic-cause-for-mis-c-complication-following-covid-19-infection/
Research Institution
Cleveland Clinic
Short Title
Research Identifies Potential Genetic Cause for MIS-C Complication Following COVID-19 Infection
Content Coordinator
Claudia Wair
Content Manager
Catey Laube Macdonald

New Blood Test to Identify Infections Could Reduce Global Antibiotic Overuse

NMRC Begins Phase 1 Testing of Diarrhea Vaccine

Are Researchers Closer to Understanding Who Is at Risk of Hospitalization from COVID-19?

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://newsblog.drexel.edu/2022/12/12/are-researchers-closer-to-understanding-who-is-at-risk-of-hospitalization-from-covid-19/
Research Institution
Drexel University
Short Title
Are Researchers Closer to Understanding Who Is at Risk of Hospitalization from COVID-19?
Content Coordinator
Claudia Wair
Content Manager
Catey Laube Macdonald

Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)

The purpose of this Notice of Funding Opportunity (NOFO) is to invite applications for the Developmental Centers for AIDS Research (D-CFAR) program to provide administrative and shared research support to enhance HIV/AIDS research. D-CFARs provide core facilities, expertise, resources, and services not readily obtained otherwise through more traditional funding mechanisms. Additionally, D-CFARs provide support to assist investigators in the development of a competitive standard CFAR. The program emphasizes interdisciplinary collaboration across all areas of HIV/AIDS research.

Centers for AIDS Research (P30 Clinical Trial Not Allowed)

The purpose of this Notice of Funding Opportunity (NOFO) is to invite applications for the Centers for AIDS Research (CFAR) program to provide administrative and shared research support to enhance HIV/AIDS research. CFARs provide core facilities, expertise, resources, and services not readily obtained otherwise through more traditional funding mechanisms. The program emphasizes interdisciplinary collaboration across all areas of HIV/AIDS research.

NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed)

The purpose of the MSPP is to develop a diverse pool of combined-degree students (e.g., MD/PhD, DDS/PhD, DVM/PhD) who have conducted their PhD dissertation research at research laboratories in the NIH Intramural Research Program. The recipients will receive rigorous training in the basic, translational, and clinical biomedical sciences to prepare them for leadership positions in biomedical careers.

Subscribe to